Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjects-Reference-Cited by-同舟云学术

Post-marketing and clinical safety experience with sodium oxybate for the treatment of alcohol withdrawal syndrome and maintenance of abstinence in alcohol-dependent subjects

Published:2019-12-30 Issue:2 Volume:19 Page:159-166
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Addolorato Giovanni¹²^ORCID,Lesch Otto-Michael³,Maremmani Icro⁴,Walter Henriette³,Nava Felice⁵,Raffaillac Quentin⁶,Caputo Fabio⁷⁸

Affiliation:

1. Alcohol Use Disorder Unit, Division of Internal Medicine, Gastroenterology and Hepatology Unit, Catholic University of Rome, A. Gemelli Hospital, Rome, Italy

2. Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy

3. Addiction Medicine, University for Psychiatry and Psychotherapy, Vienna, Austria

4. Santa Chiara University Hospital, University of Pisa, Pisa, Italy

5. Penitentiary Medicine and Drug Abuse Unit, Public Health Service Padua, Padua, Italy

6. DA Pharma, Paris, France

7. Department of Internal Medicine, SS Annunziata Hospital, University of Ferrara, Cento (Ferrara), Italy

8. “G. Fontana” Centre for the Study and Multidisciplinary Treatment of Alcohol Addiction, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2020.1709821

Reference63 articles.

1. Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level

2. Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention

3. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): Differences in characteristics and misuse

4. Safety Overview of Postmarketing and Clinical Experience of Sodium Oxybate (Xyrem): Abuse, Misuse, Dependence, and Diversion

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of sodium oxybate for the treatment of alcohol withdrawal syndrome in patients with acute alcohol-associated hepatitis: A 4-patient case report;Medicine;2024-08-02

2. Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder;Expert Opinion on Emerging Drugs;2024-04-18

3. Substitution therapy for patients with alcohol dependence: Mechanisms of action and efficacy;International Review of Neurobiology;2024

4. Current treatments of alcohol use disorder;International Review of Neurobiology;2024

5. Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment Duration;Alcohol and Alcoholism;2023-01-06